Q&A with Antoine Delafargue, MD & CTO, Total Carbon Neutrality Ventures
Month: August 2021
Sonoma captures $265m in series B
Alphabet, Eli Lilly, Dong-A ST and Alexandria Real Estate Equities backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.
Human Interest identifies $200m series D
SoftBank Vision Fund 2 took part in the 401(k) plan provider’s latest round that valued the business at $1bn, six months after it closed a series C.
Dataiku determines $4.6bn valuation
CapitalG helped data science platform Dataiku raise series E capital, which increased the company’s valuation to $4.6bn.
Meike is energised by $155m
The money was split across series A and A-plus rounds and came from investors including Chint and Sinopec.
Berry Oncology picks series B1 investors
China Merchants Capital has co-led a series B round sized at almost $99.2m that also attracted existing shareholder Legend Capital.
Daily Deal Round Up: August 4, 2021
Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.
Marvell to ingest Innovium for $1.1bn
The all-stock transaction is expected to close by the end of this year and will provide an exit to Qualcomm Ventures.
Rapyd hauls in $300m
The payment technology provider backed by Stripe raised a series E round, which will be used to further develop its offering, strengthen its network capabilities and accelerate its growth.
NuScale powers up with $152m
Several corporate investors have backed a series A5 round for the clean nuclear energy technology developer that leverages Oregon State University research.
Xi’an Eswin triumphs with $464m
China Life Private Equity Investment was among the investors in the Beijing Eswin subsidiary’s series B round, seven months after its reported series A.
Investors prescribe $232m to Yuanxin
The Tencent-backed owner of pharmaceutical platform Miaoshou Doctor has raised a series F round from new and returning investors, six months after it completed a series E.
Moderne Ventures closes second fund on $200m
The fund received commitments from real estate firms Greystar, Realogy, AvalonBay Communities, Camden Property Trust, JBG Smith and Leading Real Estate Companies of the World.
Rani jogs to $73.3m IPO
The multi-corporate-backed biologic pill developer has listed on the Nasdaq Global Market, pricing the shares below their range.